It will happen, in fact it has already happened and more than ten years ago:
Novak is tall, solemn, polite and stiff in conversation, until the conversation turns to passenger pigeons, which it always does. One of the few times I saw him laugh was when I asked whether de-extinction might turn out to be impossible. He reminded me that it has already happened. More than 10 years ago, a team that included Alberto Fernández-Arias (now a Revive & Restore adviser) resurrected a bucardo, a subspecies of mountain goat also known as the Pyrenean ibex, that went extinct in 2000. The last surviving bucardo was a 13-year-old female named Celia. Before she died — her skull was crushed by a falling tree — Fernández-Arias extracted skin scrapings from one of her ears and froze them in liquid nitrogen. Using the same cloning technology that created Dolly the sheep, the first cloned mammal, the team used Celia’s DNA to create embryos that were implanted in the wombs of 57 goats. One of the does successfully brought her egg to term on July 30, 2003. “To our knowledge,” wrote the scientists, “this is the first animal born from an extinct subspecies.” But it didn’t live long. After struggling to breathe for several minutes, the kid choked to death.
There is more here, interesting throughout. One risk is that these newly recreated animals may turn out to be efficient carriers of modern diseases. And the economic benefits of recreating extinct species are…? And here is a legal perspective:
In “How to Permit Your Mammoth,” published in The Stanford Environmental Law Journal, Norman F. Carlin asks whether revived species should be protected by the Endangered Species Act or regulated as a genetically modified organism. He concludes that revived species, “as products of human ingenuity,” should be eligible for patenting.
And are they really the same animals after all, given the imperfections in the process of cloning and recreation? The philosopher might say this:
“I would like to have an elephant that likes the cold weather,” he told me. “Whether you call it a ‘mammoth’ or not, I don’t care.”
I say we would be wise to exercise option value on this one, but of course the incentives of scientists are to do something first.